Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine

被引：7
|
作者：
Xicoy, Blanca [1 ]
Miralles, Pilar [2 ]
Morgades, Mireia [1 ]
Rubio, Rafael [3 ]
Valencia, Maria-Eulalia [4 ]
Ribera, Josep-Maria [1 ]
机构：
[1] Univ Autonoma Barcelona, ICO Hosp Germans Trias Pujol, Jose Carreras Leukemia Res Inst, Dept Clin Hematol, Badalona, Spain
[2] Hosp Gregorio Maranon, Dept Infect Dis, Madrid, Spain
[3] Hosp 12 Octubre, Dept Infect Dis, E-28041 Madrid, Spain
[4] Hosp Carlos III, Dept Infect Dis, Madrid, Spain
来源：
HAEMATOLOGICA | 2013年 / 98卷 / 08期
关键词：
Hodgkin's lymphoma; HIV-related; long-term follow up; opportunistic infections; second cancers; ACTIVE ANTIRETROVIRAL THERAPY; IMPACT; REGIMEN; HAART;
D O I：
10.3324/haematol.2012.079921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E85 / E86
页数：2
相关论文
共 50 条
  • [1] Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen
    Xicoy, Blanca
    Ribera, Josep-Maria
    Miralles, Pilar
    Berenguer, Juan
    Rubio, Rafael
    Mahillo, Beatriz
    Valencia, Maria-Eulalia
    Abella, Eugenia
    Lopez-Guillermo, Armando
    Sureda, Ana
    Morgades, Mireia
    Navarro, Jose-Tomas
    Esteban, Herminia
    LEUKEMIA & LYMPHOMA, 2009, 50 (10) : 1718 - 1720
  • [2] Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma
    Xicoy, Blanca
    Ribera, Josep-Maria
    Miralles, Pilar
    Berenguer, Juan
    Rubio, Rafael
    Mahillo, Beatriz
    Valencia, Maria-Eulalia
    Abella, Eugenia
    Lopez-Guillermo, Armando
    Sureda, Ana
    Morgades, Mireia
    Navarro, Jose-Tomas
    Esteban, Herminia
    Mate, J. L.
    Cosin, J.
    Lopez, J. C.
    Pulido, F.
    Moreno, V
    Cepeda, C.
    Gonzalez, J.
    Tellez, M. J.
    Vergas, J.
    Estrada, V
    Roca, V
    Montes, M. L.
    Arribas, J. R.
    Gonzalez-Garcia, J.
    Lacruz, J.
    Lopez, J.
    Salavert, M.
    Santos, J.
    Palacios, R.
    Marquez, M.
    Sepulveda, M. A.
    de la Torre, A.
    Rivero, A.
    Garcia, M.
    Pintado, V
    Antela, A.
    Patier, L.
    Rodriguez, L., I
    HAEMATOLOGICA, 2007, 92 (02) : 191 - 198
  • [3] Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study
    Batty, Nicolas
    Hagemeister, Fredrick B.
    Feng, Lei
    Romaguera, Jorge E.
    Rodriguez, Maria A.
    McLaughlin, Peter
    Samaniego, Felipe
    Copeland, Amanda
    Dabaja, Bouthaina S.
    Younes, Anas
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 801 - 806
  • [4] Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy
    Chand, VK
    Link, BK
    Ritchie, JM
    Shannon, M
    Wooldridge, JE
    LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 657 - 663
  • [5] Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
    Lagerlof, Ingemar
    Fohlin, Helena
    Enblad, Gunilla
    Glimelius, Bengt
    Goldkuhl, Christina
    Palma, Marzia
    Akesson, Lisa
    Glimelius, Ingrid
    Molin, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) : 1487 - 1496
  • [6] Prediction of outcome according to international prognostic score (IPS) inpatients with advanced stage human immunodeficiency virus infection (HIV)-related hodgkin's lymphoma (HL) treated with doxorubicin, bleomycin,vinblastine and dacarbazine (ABVD) and highly active antiretroviral therapy (HAART)
    Xicoy, B.
    Ribera, J. M.
    Miralles, P.
    Berenguer, J.
    Rubio, R.
    Mahillo, B.
    Valencia, M. E.
    Abella, E.
    Lopez-Guillermo, A.
    Sureda, A.
    Morgades, M.
    Navarro, J. T.
    Esteban, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 67 - 67
  • [7] Long-term events in adult patients with clinical stage IA-IIa nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin,vinblastine, and dacarbazine and adjuvant radiotherapy: A single-institution 15-year follow-up
    Brusamolino, Ercole
    Baio, Ambrogia
    Orlandi, Ester
    Arcaini, Luca
    Passamonti, Francesco
    Griva, Vassiliki
    Casagrande, William
    Pascutto, Cristiana
    Franchini, Pietro
    Lazzarino, Mario
    CLINICAL CANCER RESEARCH, 2006, 12 (21) : 6487 - 6493
  • [8] Long-term survival of a patient with human immunodeficiency virus infection and Hodgkin's lymphoma
    Diwan, AH
    Umbreit, J
    Nelson, BP
    SOUTHERN MEDICAL JOURNAL, 2002, 95 (08) : 943 - 944
  • [9] Prognostic Factors for Advanced-Stage Human Immunodeficiency Virus-Associated Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Combined Antiretroviral Therapy A Multi-Institutional Retrospective Study
    Castillo, Jorge J.
    Bower, Mark
    Bruehlmann, Jeremy
    Novak, Urban
    Furrer, Hansjakob
    Tanaka, Paula Y.
    Besson, Caroline
    Montoto, Silvia
    Cwynarski, Kate
    Abramson, Jeremy S.
    Dalia, Samir
    Bibas, Michele
    Connors, Joseph M.
    Furman, Michael
    Minh-Ly Nguyen
    Cooley, Timothy P.
    Beltran, Brady E.
    Collins, Jaime A.
    Vose, Julie M.
    Xicoy, Blanca
    Ribera, Josep-Maria
    CANCER, 2015, 121 (03) : 423 - 431
  • [10] Prognosis in Patients with Human Immunodeficiency Virus Infection and Advanced Clinical Stage Classic Hodgkin's Lymphoma
    delMoral-Diez, Juan J.
    Tuna-Aguilar, Elena Juventina
    Aguayo, Alvaro
    Olivas-Martinez, Antonio
    Agreda-Vasquez, Gladys P.
    BLOOD, 2019, 134
12345